251 related articles for article (PubMed ID: 36194364)
21. Biochemical Properties of Human D-amino Acid Oxidase Variants and Their Potential Significance in Pathologies.
Sacchi S; Cappelletti P; Murtas G
Front Mol Biosci; 2018; 5():55. PubMed ID: 29946548
[TBL] [Abstract][Full Text] [Related]
22. Properties and applications of microbial D-amino acid oxidases: current state and perspectives.
Pollegioni L; Molla G; Sacchi S; Rosini E; Verga R; Pilone MS
Appl Microbiol Biotechnol; 2008 Feb; 78(1):1-16. PubMed ID: 18084756
[TBL] [Abstract][Full Text] [Related]
23. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
Smith SM; Uslaner JM; Yao L; Mullins CM; Surles NO; Huszar SL; McNaughton CH; Pascarella DM; Kandebo M; Hinchliffe RM; Sparey T; Brandon NJ; Jones B; Venkatraman S; Young MB; Sachs N; Jacobson MA; Hutson PH
J Pharmacol Exp Ther; 2009 Mar; 328(3):921-30. PubMed ID: 19088300
[TBL] [Abstract][Full Text] [Related]
24. Contributions of spinal D-amino acid oxidase to chronic morphine-induced hyperalgesia.
Ma S; Li XY; Gong N; Wang YX
J Pharm Biomed Anal; 2015 Dec; 116():131-8. PubMed ID: 25850373
[TBL] [Abstract][Full Text] [Related]
25. Novel Treatment for the Most Resistant Schizophrenia: Dual Activation of NMDA Receptor and Antioxidant.
Lin CH; Chen YM; Lane HY
Curr Drug Targets; 2020; 21(6):610-615. PubMed ID: 31660823
[TBL] [Abstract][Full Text] [Related]
26. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.
Chumakov I; Blumenfeld M; Guerassimenko O; Cavarec L; Palicio M; Abderrahim H; Bougueleret L; Barry C; Tanaka H; La Rosa P; Puech A; Tahri N; Cohen-Akenine A; Delabrosse S; Lissarrague S; Picard FP; Maurice K; Essioux L; Millasseau P; Grel P; Debailleul V; Simon AM; Caterina D; Dufaure I; Malekzadeh K; Belova M; Luan JJ; Bouillot M; Sambucy JL; Primas G; Saumier M; Boubkiri N; Martin-Saumier S; Nasroune M; Peixoto H; Delaye A; Pinchot V; Bastucci M; Guillou S; Chevillon M; Sainz-Fuertes R; Meguenni S; Aurich-Costa J; Cherif D; Gimalac A; Van Duijn C; Gauvreau D; Ouellette G; Fortier I; Raelson J; Sherbatich T; Riazanskaia N; Rogaev E; Raeymaekers P; Aerssens J; Konings F; Luyten W; Macciardi F; Sham PC; Straub RE; Weinberger DR; Cohen N; Cohen D
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13675-80. PubMed ID: 12364586
[TBL] [Abstract][Full Text] [Related]
27. Clinical and biochemical study of d-serine metabolism among schizophrenia patients.
El-Tallawy HN; Saleem TH; El-Ebidi AM; Hassan MH; Gabra RH; Farghaly WM; Abo El-Maali N; Sherkawy HS
Neuropsychiatr Dis Treat; 2017; 13():1057-1063. PubMed ID: 28435276
[TBL] [Abstract][Full Text] [Related]
28. Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity.
Scianni M; Antonilli L; Chece G; Cristalli G; Di Castro MA; Limatola C; Maggi L
J Neuroinflammation; 2013 Aug; 10():108. PubMed ID: 23981568
[TBL] [Abstract][Full Text] [Related]
29. Discovery of a Novel Class of d-Amino Acid Oxidase Inhibitors Using the Schrödinger Computational Platform.
Tang H; Jensen K; Houang E; McRobb FM; Bhat S; Svensson M; Bochevarov A; Day T; Dahlgren MK; Bell JA; Frye L; Skene RJ; Lewis JH; Osborne JD; Tierney JP; Gordon JA; Palomero MA; Gallati C; Chapman RSL; Jones DR; Hirst KL; Sephton M; Chauhan A; Sharpe A; Tardia P; Dechaux EA; Taylor A; Waddell RD; Valentine A; Janssens HB; Aziz O; Bloomfield DE; Ladha S; Fraser IJ; Ellard JM
J Med Chem; 2022 May; 65(9):6775-6802. PubMed ID: 35482677
[TBL] [Abstract][Full Text] [Related]
30. A detailed mechanism of the oxidative half-reaction of d-amino acid oxidase: another route for flavin oxidation.
Kiss DJ; Ferenczy GG
Org Biomol Chem; 2019 Aug; 17(34):7973-7984. PubMed ID: 31407761
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterization and preliminary crystallographic data of N6-(6-carbamoylhexyl)-FAD-D-amino-acid oxidase from pig kidney, a semi-synthetic oxidase.
Stocker A; Hecht HJ; Bückmann AF
Eur J Biochem; 1996 Jun; 238(2):519-28. PubMed ID: 8681967
[TBL] [Abstract][Full Text] [Related]
32. D-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia.
Errico F; Mothet JP; Usiello A
J Pharm Biomed Anal; 2015 Dec; 116():7-17. PubMed ID: 25868730
[TBL] [Abstract][Full Text] [Related]
33. Determination of D-serine and D-alanine Tissue Levels in the Prefrontal Cortex and Hippocampus of Rats After a Single Dose of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, with Potential Antipsychotic and Antidepressant Properties.
Huang CC; Wei IH; Yang HT; Lane HY
Neurochem Res; 2023 Jul; 48(7):2066-2076. PubMed ID: 36786942
[TBL] [Abstract][Full Text] [Related]
34. d-Serine and d-Alanine Regulate Adaptive Foraging Behavior in
Saitoh Y; Katane M; Miyamoto T; Sekine M; Sakai-Kato K; Homma H
J Neurosci; 2020 Sep; 40(39):7531-7544. PubMed ID: 32855271
[TBL] [Abstract][Full Text] [Related]
35. Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.
Fradley R; Goetghebeur P; Miller D; Burley R; Almond S; Gruart I Massó A; Delgado García JM; Zhu B; Howley E; Neill JC; Grayson B; Gaskin P; Carlton M; Gray I; Serrats J; Davies CH
Neurochem Res; 2023 Oct; 48(10):3027-3041. PubMed ID: 37289348
[TBL] [Abstract][Full Text] [Related]
36. pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility.
Sacchi S; Bernasconi M; Martineau M; Mothet JP; Ruzzene M; Pilone MS; Pollegioni L; Molla G
J Biol Chem; 2008 Aug; 283(32):22244-56. PubMed ID: 18544534
[TBL] [Abstract][Full Text] [Related]
37. Contributions of spinal D-amino acid oxidase to bone cancer pain.
Huang JL; Chen XL; Guo C; Wang YX
Amino Acids; 2012 Nov; 43(5):1905-18. PubMed ID: 22996731
[TBL] [Abstract][Full Text] [Related]
38. Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study.
Habl G; Zink M; Petroianu G; Bauer M; Schneider-Axmann T; von Wilmsdorff M; Falkai P; Henn FA; Schmitt A
J Neural Transm (Vienna); 2009 Dec; 116(12):1657-65. PubMed ID: 19823762
[TBL] [Abstract][Full Text] [Related]
39. D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog.
Rojas C; Alt J; Ator NA; Thomas AG; Wu Y; Hin N; Wozniak K; Ferraris D; Rais R; Tsukamoto T; Slusher BS
Neuropsychopharmacology; 2016 May; 41(6):1610-9. PubMed ID: 26471255
[TBL] [Abstract][Full Text] [Related]
40. D-Amino acid oxidase-mediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain.
Lu JM; Gong N; Wang YC; Wang YX
Br J Pharmacol; 2012 Mar; 165(6):1941-1955. PubMed ID: 21950354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
